<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04192305</url>
  </required_header>
  <id_info>
    <org_study_id>OS impact LPV on SAT d OFA</org_study_id>
    <nct_id>NCT04192305</nct_id>
  </id_info>
  <brief_title>Impact of LPV During OFA on Postoperative Oxygen Saturation.</brief_title>
  <official_title>Observational Study Evaluating the Impact of Lung Protective Ventilation (LPV) During Opioid Free Anesthesia (OFA) on Postoperative Oxygen Saturation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AZ Sint-Jan AV</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AZ Sint-Jan AV</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study comparing patients with lung protective ventilation (LPV) following the
      consensus guidelines by Young C with patients getting routine lung ventilation, both during
      opioid free anesthesia (OFA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The paper by C Young et al describes the essential steps in protecting the lungs and
      preventing post operative pulmonary complications (PPC) like alveolar collapse.

      Alveolar collapse can be measured by oxygen saturation drop when no oxygen therapy is given,
      when full neuromuscular block (NMB) reversal and no opioid is given intra and postoperative.

      LPV means:

      tidal volume of 6 ml/kg, inspiratory-expiratory (I/E) ratio of 1/1, positive end expiratory
      pressure (PEEP) minimum 5 cmH20 and higher during laparoscopy in obese patients, Inspiratory
      oxygen concentration (FIO2) max 80% during induction and max 40 % during maintenance and
      extubation. Extubation in an awake, full NMB reversed patient getting no opioids while giving
      continuous positive airway pressure (CPAP) during withdrawal of the tube. Lung recruitment
      maneuver (LRM) when lung compliance decreases below 40 milliliter per centimeter water.
      (ml/cmH2O)
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative oxygen saturation</measure>
    <time_frame>up to maximum 4 hours</time_frame>
    <description>saturation is continuously measured in the post anesthetic area without giving oxygen until sat drops below 94%.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Oxygen Saturation</condition>
  <arm_group>
    <arm_group_label>lung protective ventilation (LPV)</arm_group_label>
    <description>lung protective ventilation low tidal volume, minimum PEEP and higher PEEP and lung recruitment based on total lung compliance, low inspiratory oxygen concentration and CPAP during extubation without prior suctioning inside the endotracheal tube.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>routine lung ventilation (LV)</arm_group_label>
    <description>ventilation and adapting PEEP, LRM and oxygen only when saturation drops.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LPV</intervention_name>
    <description>LPV means tidal volume of 6 ml/kg, inspiratory-expiratory (I/E) ratio of 1/1, positive end expiratory pressure (PEEP) minimum 5 cmH20 and higher during laparoscopy in obese patients, Inspiratory oxygen concentration (FIO2) 40 % during maintenance and extubation while also giving CPAP. Lung recruitment maneuver (LRM) when lung compliance decreases below 40 ml/cmH2O.</description>
    <arm_group_label>lung protective ventilation (LPV)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>routine LV</intervention_name>
    <description>Give volume en frequency as required by end tidal carbon dioxide, PEEP and LRM only when saturation drops intra operative, no requirement to use low FIO2 and CPAP during extubation.</description>
    <arm_group_label>routine lung ventilation (LV)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        bariatric surgery is performed in obese patients with BMI &gt; 35
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bariatric surgery

          -  morbid obesity ( BMI &gt; 35)

        Exclusion Criteria:

          -  patients with pre existing severe cardio-pulmonary diseases having oxygen saturation
             without oxygen below 94%.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Paul Mulier</last_name>
    <role>Principal Investigator</role>
    <affiliation>AZSint Jan AV</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Paul Mulier</last_name>
    <phone>+32486729203</phone>
    <email>jan.mulier@azsintjan.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mulier</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Azsintjan</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 2, 2019</study_first_submitted>
  <study_first_submitted_qc>December 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>December 6, 2019</last_update_submitted>
  <last_update_submitted_qc>December 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>AZ Sint-Jan AV</investigator_affiliation>
    <investigator_full_name>Jan Mulier</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

